Ethanol (CID 702) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(6)
 
 
Inactive(151)
 
 
Inconclusive(6)
 
 
Unspecified(1586)
 
 
Top Targets:
7TM GPCR Srx(12)
 
 
p450(11)
 
 
 
7TM GPCR Srsx(9)
 
 
NR LBD PPAR(5)
 
 
NR LBD TR(4)
 
 
BioAssay Types:
Confirmatory(141)
 
 
 
Literature(78)
 
 
 
 
 
BioActivity Types:
IC50(116)
 
 
Potency(105)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 1741    Data Row: 1749   Total Pages: 35   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID48413739]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other]
View
2
[SID48413739]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
3
[SID48414916]
 DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity [AID1188, Type: other]
View
4
[SID48415981]
 DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
5
[SID103176346]
 Compound tested for blood AcH levels in naive rat was determined [AID169653, Type: Literature]
View
6
[SID48413739]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
7
[SID17389892]
 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other]
View
8
[SID103176346]
IC50 DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) [AID625147, Type: other] [gi:20141559]
View
9
[SID103176346]
IC50 DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) [AID625193, Type: other]Acetylcholinesterase [gi:113037]
View
10
[SID103176346]
IC50 DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) [AID625194, Type: other]Adenosine receptor A [gi:231473]
View
11
[SID103176346]
IC50 DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) [AID625194, Type: other]Adenosine receptor A [gi:231473]
View
12
[SID103176346]
IC50 DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) [AID625194, Type: other]Adenosine receptor A [gi:231473]
View
13
[SID103176346]
IC50 DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) [AID625195, Type: other]Adenosine receptor A2 [gi:543740]
View
14
[SID103176346]
IC50 DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) [AID625195, Type: other]Adenosine receptor A2 [gi:543740]
View
15
[SID103176346]
IC50 DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) [AID625195, Type: other]Adenosine receptor A2 [gi:543740]
View
16
[SID103176346]
IC50 DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other]Alpha-1D adrenergic receptor [gi:1168243]
View
17
[SID103176346]
IC50 DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other]Alpha-1D adrenergic receptor [gi:1168243]
View
18
[SID103176346]
IC50 DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other]Alpha-1D adrenergic receptor [gi:1168243]
View
19
[SID103176346]
IC50 DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other]Alpha-2A adrenergic receptor [gi:1351829]
View
20
[SID103176346]
IC50 DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other]Alpha-2A adrenergic receptor [gi:1351829]
View
21
[SID103176346]
IC50 DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) [AID625202, Type: other]Alpha-2B adrenergic receptor [gi:27151763]
View
22
[SID103176346]
IC50 DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) [AID625202, Type: other]Alpha-2B adrenergic receptor [gi:27151763]
View
23
[SID103176346]
IC50 DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other]Alpha-2C adrenergic receptor [gi:20141211]
View
24
[SID103176346]
IC50 DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other]Alpha-2C adrenergic receptor [gi:20141211]
View
25
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) [AID625204, Type: other]Beta-1 adrenergic receptor [gi:48429211]
View
26
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) [AID625204, Type: other]Beta-1 adrenergic receptor [gi:48429211]
View
27
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) [AID625204, Type: other]Beta-1 adrenergic receptor [gi:48429211]
View
28
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) [AID625205, Type: other]Beta-2 adrenergic receptor [gi:296439450]
View
29
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) [AID625205, Type: other]Beta-2 adrenergic receptor [gi:296439450]
View
30
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) [AID625205, Type: other]Beta-2 adrenergic receptor [gi:296439450]
View
31
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) [AID625205, Type: other]Beta-2 adrenergic receptor [gi:296439450]
View
32
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) [AID625206, Type: other]Beta-3 adrenergic receptor [gi:461604]
View
33
[SID103176346]
IC50 DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) [AID625206, Type: other]Beta-3 adrenergic receptor [gi:461604]
View
34
[SID103176346]
IC50 DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A) [AID625209, Type: other]Type-2 angiotensin II receptor [gi:1703214]
View
35
[SID103176346]
 Antifungal activity against Candida albicans DAY 185 assessed as inhibition of biofilm formation after 24 hrs by XTT reduction assay [AID531319, Type: Literature]
View
36
[SID103176346]
 Antifungal activity against Candida albicans DAY 185 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay [AID531320, Type: Literature]
View
37
[SID103176346]
 Antifungal activity against Candida albicans K1 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay [AID531321, Type: Literature]
View
38
[SID103176346]
 Antifungal activity against Candida parapsilosis 5986 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay [AID531322, Type: Literature]
View
39
[SID103176346]
 Antifungal activity against Candida glabrata 5740 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay [AID531323, Type: Literature]
View
40
[SID103176346]
 FICI in Candida albicans DAY 185 after 24 hrs in presence of flucanozole [AID531324, Type: Literature]
View
41
[SID103176346]
 Antifungal activity against Candida albicans DAY 185 grown as planktonic cells by CLSI method [AID531325, Type: Literature]
View
42
[SID103176346]
 Antifungal activity against Candida albicans K1 grown as planktonic cells by CLSI method [AID531326, Type: Literature]
View
43
[SID103176346]
 Antifungal activity against Candida parapsilosis 5986 grown as planktonic cells by CLSI method [AID531327, Type: Literature]
View
44
[SID103176346]
 Antifungal activity against Candida glabrata 5740 grown as planktonic cells by CLSI method [AID531328, Type: Literature]
View
45
[SID103176346]
 Antifungal activity against Candida albicans DAY 185 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method [AID531531, Type: Literature]
View
46
[SID103176346]
 Antifungal activity against Candida albicans K1 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method [AID531532, Type: Literature]
View
47
[SID103176346]
 Antifungal activity against Candida parapsilosis 5986 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method [AID531533, Type: Literature]
View
48
[SID103176346]
 Antifungal activity against Candida glabrata 5740 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method [AID531534, Type: Literature]
View
49
[SID103176346]
 Inhibition of bovine tubulin polymerization at 10 uM measured every 30 seconds for 60 mins by spectrophotometry relative to control [AID548640, Type: Literature]
View
50
[SID103176346]
 Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature]
View